Publication

Article

Pharmaceutical Technology

Pharmaceutical Technology-09-02-2014
Volume38
Issue 9

Excellims Ion-Mobility Separator Interfaces with Mass Spectrometers

The MA3100 high performance ion mobility pre-separator (HPIMS) from Excellims has been built to interface with multiple mass spectrometer (MS) product lines from Thermo Fisher Scientific.

The MA3100 high performance ion mobility pre-separator (HPIMS) from Excellims has been built to interface with multiple mass spectrometer (MS) product lines from Thermo Fisher Scientific. The MA3100 enhances MS technology by increasing versatility, simplifying complex spectra, and allowing targeted analysis of gas phase ions.

The HPIMS-Orbitrap MS combination delivers ultra-high-resolution separation of complex samples in both ion mobility and m/z domains and provides information about the structure and identity of molecular ions. The MA3100 is exchangeable with the current ionization sources of the MS. The technology attains high-resolution separation that has not been possible on previously existing systems and routinely performs separations with a resolving power of more than 70.

ref="http://www.excellims.com" target="_blank" ref="nofollow">Excellims

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content